Related references
Note: Only part of the references are listed.Cognitive Outcomes Associated With Long-Term, Regular, Recreational Cannabis Use in Adults: A Meta-Analysis
Monica E. Lovell et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2020)
Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning
Teresa Sanchez-Gutierrez et al.
EUROPEAN PSYCHIATRY (2020)
History of Lifetime Cannabis Use Is Associated with Better Cognition and Worse Real-World Functioning in Schizophrenia Spectrum Disorders
Isabel Menendez-Miranda et al.
EUROPEAN ADDICTION RESEARCH (2019)
Cannabis Addiction and the Brain: a Review
Amna Zehra et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2018)
Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults A Systematic Review and Meta-analysis
J. Cobb Scott et al.
JAMA PSYCHIATRY (2018)
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis
Glenn E. Hunt et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
The link between schizophrenia and substance use disorder: A unifying hypothesis
Jibran Y. Khokhar et al.
SCHIZOPHRENIA RESEARCH (2018)
Does Cannabis Use Cause Declines in Neuropsychological Functioning? A Review of Longitudinal Studies
Raul Gonzalez et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2017)
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
Ashleigh L. Osborne et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition
Siri Helle et al.
PSYCHIATRY RESEARCH (2017)
An Integrative Perspective on the Role of Dopamine in Schizophrenia
Tiago V. Maia et al.
BIOLOGICAL PSYCHIATRY (2017)
Adolescent cannabis use, change in neurocognitive function, and high-school graduation: A longitudinal study from early adolescence to young adulthood
Natalie Castellanos-Ryan et al.
DEVELOPMENT AND PSYCHOPATHOLOGY (2017)
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis
Tabea Schoeler et al.
LANCET PSYCHIATRY (2017)
The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis
T. Schoeler et al.
PSYCHOLOGICAL MEDICINE (2016)
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Suzanne H. Gage et al.
BIOLOGICAL PSYCHIATRY (2016)
Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review
Samantha J. Broyd et al.
BIOLOGICAL PSYCHIATRY (2016)
Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
C. Mokrysz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
Anthony A. Grace
NATURE REVIEWS NEUROSCIENCE (2016)
Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults
Florian Ganzer et al.
NEUROPSYCHOLOGY REVIEW (2016)
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use
Rebecca C. Hanna et al.
SCHIZOPHRENIA BULLETIN (2016)
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Arianna Marconi et al.
SCHIZOPHRENIA BULLETIN (2016)
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives
Silvana Galderisi et al.
SCHIZOPHRENIA RESEARCH (2016)
Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders
Mary E. Kelley et al.
SCHIZOPHRENIA RESEARCH (2016)
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Nora D. Volkow et al.
JAMA PSYCHIATRY (2016)
Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls
Emre Bora et al.
SCHIZOPHRENIA BULLETIN (2015)
Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study
Ragnar Nesvag et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2015)
Revisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behavior
A. George Awad et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2015)
The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature
Valentina Lorenzetti et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
The adverse health effects of chronic cannabis use
Wayne Hall et al.
DRUG TESTING AND ANALYSIS (2014)
The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS)
Sarah Tosato et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people
Li-Tzy Wu et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Cannabis use, cognition and brain structure in first-episode psychosis
Paulo Jannuzzi Cunha et al.
SCHIZOPHRENIA RESEARCH (2013)
Neurocognitive Functioning and Cannabis Use in Schizophrenia
Aviv Segev et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
Murat Yuecel et al.
SCHIZOPHRENIA BULLETIN (2012)
Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms
Paul D. Morrison et al.
NEUROPSYCHOPHARMACOLOGY (2011)
The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis
Rachel A. Rabin et al.
SCHIZOPHRENIA RESEARCH (2011)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Cognitive Functioning in Children and Adolescents in Their First Episode of Psychosis Differences Between Previous Cannabis Users and Nonusers
Elena de la Serna et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2010)
Neurophysiological and cognitive effects of smoked marijuana in frequent users
Carl L. Hart et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia
P. A. Ringen et al.
PSYCHOLOGICAL MEDICINE (2010)
Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
Johanna Koskinen et al.
SCHIZOPHRENIA BULLETIN (2010)
High-potency cannabis and the risk of psychosis
Marta Di Forti et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Cannabis use and cognition in schizophrenia
Else-Marie Loberg et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2009)
Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC)
Claudine C. Hunault et al.
PSYCHOPHARMACOLOGY (2009)
Academic attainment: a predictor of psychiatric disorders?
Siow Ann Chong et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2009)
Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis
Stephane Potvin et al.
SCHIZOPHRENIA RESEARCH (2008)
Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis
I. Mata et al.
PSYCHOLOGICAL MEDICINE (2008)
Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation
L Chang et al.
BRAIN (2006)
Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use
F Musshoff et al.
THERAPEUTIC DRUG MONITORING (2006)
Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course
TK Larsen et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Identification of separable cognitive factors in schizophrenia
KH Nuechterlein et al.
SCHIZOPHRENIA RESEARCH (2004)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
Cognitive measures in long-term cannabis users
HG Pope et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
A neurobiological basis for substance abuse comorbidity in schizophrenia
RA Chambers et al.
BIOLOGICAL PSYCHIATRY (2001)
Share Paper
